See the following -

Viratech Announces Agreement For License Of Technology Platform For Cancer Patients

Press Release |, Viratech Corp. | May 30, 2013

Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for a license issued from Chris Ryan and Kevin Buckman for a patent-pending, provisional application titled "Method of Lowering a Cancer Patient's Morbidity Rate by Increasing Quality of Life of Patient by Leveraging Cause-Based Electronic Social Support Networks." Read More »

Viratech Corp. Publishes e-Book On Open Source Biotech Research

Press Release | Viratech Corporation | February 27, 2013

[Viratech Corp.] announced today that it has published its e-Book on open source biotech research. The book [...] describes how the first open source biotech research social network platform works to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. Read More »

Will Hackers Find Bioweapon Secrets In The Cloud?

Adam Mazmanian | FCW | April 1, 2014

The collision of big data and decoded genetic information is creating a wealth of opportunities for biologists, engineers and public health researchers. However, there is also the potential that advances in computing and genetics are providing potentially catastrophic opportunities for malefactors to hack into research computers to find information that could be adapted to create biological weapons.

Read More »

John F. Kennedy Center for Performing Arts in Washington D.C. Hosts TEDMED 2012 Conference

Event Details
April 11, 2012 - 8:00am - April 13, 2012 - 5:00pm
John F. Kennedy Center for the Performing Arts Washington DC
United States

TEDMED announced that the 2012 edition of the conference will take place in Washington, DC at the John F. Kennedy Center for the Performing Arts from April 11-13, 2012. From 2009 to 2011, San Diego hosted TEDMED, drawing strong attendance from regional biotech companies and technology developers. The move to the Nation's Capital and the Kennedy Center will place TEDMED in the center of healthcare policymaking, regulation, and research funding and will accelerate collaboration among government, science, industry, academia, technology, media and the arts... Read More »